Healthcare Pharmaceutical Biotech

NexTel Medical Corp. Announces Strategic Joint Venture to Commercialize Breakthrough Patented Hair Regeneration Technology

September 29, 2026 12:40 PM

NexTel Medical Corp. (OTCID:MAJI) ("NexTel" or the "Company"), a clinical-stage biotechnology leader pioneering proprietary exosome-based delivery systems and diagnostic technologies, today announced the execution of a definitive Joint Venture Agreement to commercialize and scale a patented, high-potency hair regeneration formula. The strategic partnership targets a rapidly expanding market opportunity. The U.S. hair restoration market currently...

Read more

NCQA Awards Sharecare Three-Year Health Outcomes Accreditation

September 29, 2026 11:30 AM

Sharecare, the digital health enablement company that helps to improve care quality, drive better outcomes, and lower costs across the healthcare ecosystem, today announced it has received a three-year Health Outcomes Accreditation by the National Committee for Quality Assurance (NCQA). Three-year accreditation is the highest Accreditation status awarded by NCQA. The Health Outcomes accreditation demonstrates Sharecare's strong performance...

Read more

How Much Is Facial Feminization Surgery Out-of-Pocket Cost?

September 29, 2026 11:00 AM

Transgender patients researching the out-of-pocket cost of facial feminization surgery (FFS) now have a clear answer in the Pacific Northwest. Dr. Javad Sajan at Allure Esthetic, a top nationally recognized plastic surgeon, performs complete facial feminization surgery at a cost of $35,000. The price covers surgeon fees, facility fees, and anesthesia costs, giving patients a single transparent figure with no hidden charges. He was featured in...

Read more

MGMA Attendees Signal Intensifying Financial, Coverage and Technology Pressures for Medical Practices Entering 2027

September 29, 2026 10:00 AM

Black Book Research surveyed seventy-four attendees of the MGMA Annual Conference, taking place September 27-30 in San Antonio, to examine medical practice concerns before the November midterm elections and entering 2027. The assessment addresses three interconnected priorities: reimbursement and financial sustainability, patient coverage and affordability, and the performance of healthcare information technology. Respondents, classified by...

Read more

Genflow Biosciences PLC Announces Exercise of Warrants and Issue of Equity

September 29, 2026 9:32 AM

Genflow (LSE:GENF)(OTCQB:GENFF) ("Genflow" or the "Company"), a biotechnology company focused on the development of gene therapies for age-related diseases announces that it has received notices of exercise of warrants for a total of 28,124,999 new ordinary shares in the capital of the Company (the "Warrant Shares") with gross proceeds amounting to £309,375. The Warrant Shares comprise 28,124,999 new ordinary shares being issued pursuant to the...

Read more

Cosmos Health's CosmoFarm Reaches Record Annualized Revenue Above $60 Million, Up 4.3x Under Cosmos Health Ownership, as Robotics and AI Build Capacity to Support Over $100 Million in Annualized Revenue

September 29, 2026 9:30 AM

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today provided an update on its wholly owned pharmaceutical distribution subsidiary, CosmoFarm S.A. ("CosmoFarm"), which delivered record revenue of over $15 million in the second quarter of 2026, representing an annualized revenue run-rate of over $60 million. A Leading Pharmaceutical Distribution Platform CosmoFarm...

Read more

Nearly Every Endotoxin Certificate Reports 'Pass.' Almost None Report the Number, Crescent Bioresearch Analysis Finds

September 29, 2026 9:23 AM

Crescent Bioresearch, a supplier of laboratory compounds/reagents, has published an analysis of how bacterial endotoxin is reported on certificates of analysis across the chemical supply industry, where purity is reported almost universally, identity is common and a numerical endotoxin value is virtually extinct. The analysis starts from the certificate itself, takes it apart, and follows the one measurement that many suppliers have replaced...

Read more

Medical Care Technologies Inc. (OTCID:MDCE) Reports First-Pass Results From Volunteer Image Evaluation Inside Melanoma Scan Beta

September 29, 2026 8:57 AM

Medical Care Technologies Inc. (OTCID:MDCE) today reported first-pass results from internal evaluation of its initial volunteer-submitted image datasets for MDCE Melanoma Scan Beta. The update follows the September 16 announcement that the first human volunteer datasets had been received and the September 23 announcement that internal review had begun. Those releases established collection and the start of analysis. This release reports what...

Read more

Value-Based Care Is Hard, but It's Worth Getting Right

September 29, 2026 8:45 AM

Originally published on CVS Health Company Newsroom Key points Value-based primary care has stalled in many places not because the model is wrong, but because too many have approached it as a contracting exercise, signing the risk deal and documenting patients' clinical conditions, instead of the harder work of integrating care around the patient. Scaling it takes connecting the whole system around one patient: the health plan, primary care,...

Read more

NanoViricides, Inc. Has Filed its Annual Report: Broad-spectrum Antiviral NV-387 Is In Phase II Clinical Trials

September 29, 2026 8:45 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed its Annual Report on Form 10-K for the fiscal year ending June 30, 2026 with the Securities and Exchange Commission (SEC) on Monday, September 28, 2026. The report can be accessed at the SEC website (https://www.sec.gov/ix?doc=/Archives/edgar/data/0001379006/000110465926111390/nnvc-20260630x10k.htm). Accomplishments in Reported Fiscal Year ending June 30, 2026 In...

Read more

TillaCare Expands Nationwide Access to UriCap(TM) Female, Simplifying External Urine Collection for Women at Home

September 29, 2026 8:00 AM

TillaCare announced today the expanded nationwide availability of UriCapTM Female, an innovative female external urine collection device designed to improve at-home urinary incontinence care for women, without the need for suction or adhesives. UriCapTM Female is now available through Cardinal Health, McKesson and Milliken Medical's home care catalogs and is accessible through major durable medical equipment (DME) outlets. Medicare reimbursement...

Read more

Gedeon Richter Launches Online Platform for Transdiagnostic Global Impression Scales and New Caregiver Book at Next Step Conference

September 29, 2026 8:00 AM

Gedeon Richter welcomed 145 participants from 27 countries to the latest edition of Next Step, the company's international conference for psychiatrists, held in September at the Hungarian Academy of Sciences. "At Gedeon Richter, we see partnerships as a cornerstone of advancing psychiatric care. By supporting healthcare professionals, patients, and caregivers alike, we can help create meaningful improvements in outcomes, functioning, and quality...

Read more

Who Does the Best Tummy Tuck in Sarasota?

September 29, 2026 8:00 AM

As demand for abdominoplasty continues to grow along Florida's Gulf Coast, patients researching tummy tuck surgery in Sarasota face a crowded field of providers and a difficult question: who delivers the best results? Based on board certifications, surgical volume, industry recognition, and verified patient outcomes, the answer that consistently emerges is clear. Awarded as the Top Doctor by SRQ multiple times, the best tummy tuck in Sarasota is...

Read more

As GLP-1 Care Enters Its Second Act, T·TIME Launches Fixed-Rate Cash-Pay Program

September 29, 2026 7:20 AM

The first act of the GLP-1 boom was about getting treatment. The second is increasingly about staying on it. After years defined by shortages, waiting lists and extraordinary demand, obesity medicine is settling into a different kind of reality: refills, follow-up, dose adjustments and the economics of treatment that may extend well beyond the initial weight-loss phase. T·TIME is launching its injectable program into that second act. The...

Read more

Preliminary Results of Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer Accepted for Presentation at Annual American College of Gastroenterology Meeting

September 29, 2026 4:30 AM

Jaguar Health, Inc. (Nasdaq:JAGX) (Jaguar) family company Napo Pharmaceuticals (Napo) today announced the acceptance of an abstract on preliminary results of an ongoing open-label study of the company's crofelemer powder for oral solution in adult patients with short bowel syndrome with intestinal failure (SBS-IF) for presentation at the American College of Gastroenterology Annual Scientific Meeting (ACG 2026). ACG 2026 takes place October 9-14,...

Read more

Epitalon Peptide Research Brings Renewed Attention to Telomeres and Cellular Aging

September 29, 2026 2:25 AM

Recent research examining the effects of Epitalon peptide on telomere-maintenance mechanisms has renewed attention to the peptide as scientists investigate cellular aging and healthspan amid a rapidly aging global population. Growing scientific interest in longevity and healthy aging is putting increased attention on telomeres, telomerase activity and cellular senescence. Epitalon, a short peptide consisting of four amino acids, has been...

Read more

Spago Nanomedical to Participate in Several International Industry Conferences During Autumn 2026

September 29, 2026 2:20 AM

Spago Nanomedical AB (publ) (STO:SPAGO.ST)(FRA:7UX.F) today announces that the company will participate in five international conferences during autumn 2026, spanning nuclear medicine, radionuclide therapy and life science. The conferences include both scientific meetings and business development- and investor-oriented events, providing Spago Nanomedical with an opportunity to follow the latest developments in the field and engage with...

Read more

Genflow Biosciences PLC Announces Half-year Financial Report

September 29, 2026 2:00 AM

Genflow (LSE:GENF)(OTCQB:GENFF) is pleased to announce its half year results for the six-month period ended 30 June 2022. Chairman's Statement It is my pleasure to update shareholders of Genflow Biosciences Plc ("Genflow" or the "Company") on our performance during the first six months of 2026. As of 30 June 2026, Genflow reached a landmark milestone with the successful completion of SLAB, our lead canine healthspan and sarcopenia clinical trial...

Read more

The Next Decade of Medical AI: How Humans and AI Collaborate - A Conversation Between Kevin Kelly and Dr. Ning Song of Diagens Tech (2526. HK)

September 28, 2026 10:36 PM

On 25 September, during the 5th Global Digital Trade Expo held in China, the 2026 Festival of Medical AI hosted by Diagens Technology Co., Ltd. (2526. HK, Diagens‑B, "Diagens Tech") , themed "the Next Decade of Medical AI", brought together Kevin Kelly, futurist and founding editor-in-chief of Wired magazine, and Dr. Ning Song, Founder and Chairman of the Board of Diagens Tech. The two discussed the industrialisation of medical AI, the future...

Read more

Dr. Irfan Atcha: What a Good Second Opinion on Dental Implants Should Tell You

September 28, 2026 9:10 PM

Why a second opinion matters here Dental implant treatment is not a small decision. It can involve bone grafting, extended timelines, and a plan that touches every remaining tooth in the mouth. Dr. Irfan Atcha has spent close to thirty years in Chicago treating patients who need full rehabilitation with dental implants, and he says a second opinion is one of the most useful steps a patient can take before starting. "A second opinion is not about...

Read more